Our center is an independent clinical research facility based in San Diego. ARI conducts outpatient trials with an emphasis in Psychiatry, Neurology and Dermatology. We have successfully completed trials for Alzheimer's Disease, Vascular Dementia, Anxiety, Panic, Bipolar Disorder, Schizophrenia and Schizoaffective Disorders, Post Traumatic Disorder, Epilepsy, Social Phobia, Depression, Mild Cognitive Impairment, Acne, Psoriasis, Rosacea, Atopic Dermatitis, Wound healing and Onychomycosis.

ARI has been involved in clinical research studies since 1994. We focus on Phase II, III and IV trials for adults and children. The leader of our investigative team has over 25 years experience conducting clinical trials. Our clinical research staff adhere to ARI Standard Operating Procedures that are in compliance with ICH guidelines and FDA regulations. Our staff has been trained in inter-rater reliability and Good Clinical Practices (GPCs).

Our board certified dermatologist has experience in the following therapeutic areas: Psoriasis, Acne, Rosacea, Onychomycosis, Wound Healing, Eczema, Atinic Karatosis, Basal Cell Carcinoma, Squamous Cell Carcinoma, Contact Dermatitis. In addition our Dermatologist specializes in Mohs Micrographic Surgery, Skin Cancer Treatments, Facial Rejuvenation, Botox Injections, Chemical Peels, Laser Treatments, Microdermabrasion, Sclerotherapy, Cosmetic Surgery, tumescent liposuction, eyelid and face-lift surgery.

ARI has conducted over 100 CNS clinical trials! The staff consists of 5 CCRCs, 2 CRCs and a full-time laboratory tech and two Clinical Managers.

Site Experience and Information - CNS Studies
Chris Southard, MA, MFT, Director of Clinical Operations
8989 Rio San Diego Drive, Suite 350
San Diego, CA 92108
Phone: 619-688-6565
Fax: 619-688-6569

Site Experience and Information - Dermatology Studies
Danielle McNulty, Dermatology Program Manager
8989 Rio San Diego Drive, Suite 350
San Diego, CA 92108
Phone: 619-688-6565
Fax: 619-688-6569

The site is centrally located in Mission Valley, close to the Marriott and the Trolley Station. Our facility is located near all major highways and the airport. Our site has adequate parking and is easily accessible using public transportation. Volunteers will enjoy the comfort of a professional medical environment where confidentiality is respected and maintained. Our laboratory is in compliance with OSHA requirements and provides our staff and volunteers with a safe place to perform procedures. Sponsor representatives will enjoy a comfortable and quiet environment to work.

Psychiatry and Neurology: Charles H. Merideth, M.D.
Charles Merideth, M.D. has been conducting clinical trials since 1974. He has participated in over 160 trials and has over 15 publications. Dr. Merideth attended Washington University School of Medicine and interned in medicine at Michael Reese Hospital. He did his residency in Psychiatry at Barnes Hospital, St. Louis, followed by several positions in hospitals and private practice before founding ARI in 1994. He currently serves as Principal Investigator and Medical Director/CEO of Affiliated Research Institute.

Dermatology: Walter K. Nahm, M.D., PH.D.
Walter K. Nahm, M.D., Ph.D. is a board-certified dermatologist. Dr. Nahm completed his dermatology specialty training at Boston University School of Medicine/Roger Williams Medical Center, where he was honored as chief resident. Dr. Nahm specializes in the Mohs Micrographic Surgery technique, which is the most precise and effective manner to treat skin cancer. His other specialties include laser and cosmetic surgery. As a fellow of the American Academy of Cosmetic Surgery and the American Society for Dermatologic Surgery, he has expertise in tumescent liposuction and eyelid and face-lift surgery. In addition, Dr. Nahm has extensive experience in laser therapy for wrinkles, brown spots, blood vessels, birthmarks and vascular anomalies. Other areas of expertise include Botox®, injectable fillers (e.g., Resylane®, Radiesse™, Hylaform® and Capitque™), fat transfer, chemical skin rejuvenation, leg vein treatment (sclerotherapy) and acne scar treatment. He has performed extensive research on intense pulsed light (IPL™) technology and the TermaCool™ device (allowing for the non-surgical facelift) and was recently honored for his work.

ARI staff adheres to documented Standard Operating Procedures (SOPs) that follow Food and Drug Administration (FDA) regulations and International Conference on Harmonization (ICH) guidelines. Our Clinical Research Coordinators and Sub investigators have completed formal, annual Inter-Rater Reliability training on psychiatric and neurologic ratings scales frequently used in CNS clinical trials.

Executive Management Team
Charles H. Merideth, MD, CEO
Kevin Ohler, BS, CFO
Chris Southard, MA, MFT, Director of Clinical Operations
Alexandra Merideth, Director of Quality Management
Danielle McNulty, Dermatology Program Manager

ARI works with patient volunteers from the local communities. Our strong relations with psychiatrists, psychologists, internists, general practitioners, social workers and dermatologists comprise our Professional Research Network (PRN). We also advertise our current studies on the radio and television and these efforts continue to draw new patient populations to research.

Uniqueness of ARI
ARI is proud to specialize in Central Nervous System and Dermatology research. Our experienced psychiatrists, dermatologists and CRCs are competent in continually meeting and exceeding enrollment goals, producing clean and supported data. ARI conducts internal Quality Management audits and Quantity through rapid IRB approval, regulatory and ING submissions as well as appropriate volunteer recruitment. ARI works with patients, sponsor and community to bring "Tomorrow's Treatment Today".

CenterWatch is listing the following trials that are actively recruiting patients at this center.

• A 12-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel Groups, Multicenter, Long-Term Safety Study of MK-0928 in the Treatment of Elderly Outpatients with Primary Insomnia
• Drug Trial evaluating Seroquel versus Placebo for the Treatment of Patients with Bipolar Depression.
• If you experience difficulty Initiating Sleep, Maintaining Sleep or Nonrestorative sleep we are conducting a Double-Blind, Randomized, Multicenter, Placebo-Controlled, Efficacy and Safety Study in the Treatment of Adult Outpatients With Primary Insomnia.

For more information, please contact:

Kevin Ohler
Affiliated Research Institute, Inc.
8989 Rio San Diego Drive, Suite 350
San Diego, CA 92108 USA
Phone: 619-688-6565
Fax: 619-308-1766
E-mail:

If you are interested in contacting this center to discuss placing a clinical trial there, please complete and send the E-mail form below. A representative from the research center will then follow up with you.

Name:
Address:
City:
State:
Zip:
Phone:
Email address:
Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

Last updated on August 21, 2008